<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication" xmlns:n2016="http://publications.europa.eu/resource/schema/ted/2016/nuts" xsi:schemaLocation="http://publications.europa.eu/resource/schema/ted/R2.0.9/publication TED_EXPORT.xsd" VERSION="R2.0.9.S03.E01" DOC_ID="424059-2019" EDITION="2019174"><TECHNICAL_SECTION><RECEPTION_ID>19-435647-001</RECEPTION_ID><DELETION_DATE>20191215</DELETION_DATE><FORM_LG_LIST>DE </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>174</NO_OJ><DATE_PUB>20190910</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2019/S 174-424059</NO_DOC_OJS><URI_LIST><URI_DOC LG="DE">http://ted.europa.eu/udl?uri=TED:NOTICE:424059-2019:TEXT:DE:HTML</URI_DOC></URI_LIST><LG_ORIG>DE</LG_ORIG><ISO_COUNTRY VALUE="DE"/><IA_URL_GENERAL>https://www.centogene.com</IA_URL_GENERAL><ORIGINAL_CPV CODE="33650000">General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</ORIGINAL_CPV><n2016:PERFORMANCE_NUTS CODE="DE803">Rostock, Kreisfreie Stadt</n2016:PERFORMANCE_NUTS><n2016:CA_CE_NUTS CODE="DE803">Rostock, Kreisfreie Stadt</n2016:CA_CE_NUTS><n2016:TENDERER_NUTS CODE="DE212">München, Kreisfreie Stadt</n2016:TENDERER_NUTS><VALUES><VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="USD">65000.00</VALUE></VALUES></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20190906</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="8">Other</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="T">Negotiated without a prior call for competition</PR_PROC><RP_REGULATION CODE="4">European Union</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01B03</HEADING><INITIATOR>01</INITIATOR></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Гepмaния</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Общи противовъзпалителни средства за системна употреба, ваксини, антинеопласти и имуномодулатори</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Německo</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Antiinfektiva pro systémové užití, očkovací látky, antineoplastika a imunomodulátory</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Tyskland</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Antiinfektive midler til systemisk brug, vacciner, cytostatike/cytotoxiske midler samt immunmodulerende midler</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Deutschland</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Antiinfektiva zur systemischen Anwendung, Impfstoffe, Antineoplastika und Immunmodulatoren</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Γερμανία</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Φάρμακα κατά των λοιμώξεων συστηματικής χρήσης, εμβόλια, αντινεοπλασματικά και ανοσορρυθμιστικά φάρμακα</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Germany</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>Alemania</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Antiinfecciosos generales para uso sistémico, vacunas, antineoplásicos e inmunomoduladores</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Saksamaa</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Üldised infektsioonivastased ained süsteemseks kasutamiseks, vaktsiinid, antineoplastilised ja immuunmoduleerivad ained</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Saksa</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Systeemisesti vaikuttavat infektiolääkkeet, rokotteet sekä syöpälääkkeet ja immunomodulantit</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Allemagne</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Anti-infectieux généraux à usage systémique, vaccins, antinéoplasiques et immunomodulateurs</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Ghearmáin, an</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Njemačka</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Opća protuupalna sredstva za sustavno liječenje, cjepiva, antineoplastična sredstva i imunomodulatori</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Németország</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Általános fertőzésellenes szerek szisztémás használatra, vakcinák, daganatellenes és immunmodulátor szerek</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Germania</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Antinfettivi generali per uso sistemico, vaccini, agenti antineoplastici e immunomodulatori</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Vokietija, VFR</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Sistemiškai veikiantys priešinfekciniai vaistai, vakcinos, antinavikiniai vaistai ir imunomoduliatoriai</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Vācija</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Vispārēji pretinfekcijas līdzekļi sistēmiskai lietošanai, vakcīnas, antineoplastiskie līdzekļi un imūnmodulatori</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>il-Ġermanja</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Anti-infettivi ġenerali għall-użu sistematiku, vaċċini, antineoplastika u aġenti immunomodulaturi</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Duitsland</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Algemene infectiewerende middelen voor systemisch gebruik, vaccins, antineoplastica en immunomodulerende middelen</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Niemcy</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Ogólne środki przeciwinfekcyjne do użytku ogólnoustrojowego, szczepionki, środki przeciwnowotworowe oraz immunomodulacyjne</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Alemanha</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Anti-infecciosos gerais de uso sistémico, vacinas, antineoplásicos e imunomoduladores</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Germania</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Antiinfecţioase generale pentru uz sistemic, vaccinuri, antineoplazice şi imunomodulatoare</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Nemecko</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Všeobecné antiinfekčné látky na systémové použitie, očkovacie látky, antineoplastické prostriedky a imunomodulačné činidlá</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Nemčija</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Antimikotiki za sistemsko zdravljenje, cepiva, zdravila z delovanjem na novotvorbe in imunomodulatorji</P></TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Tyskland</TI_CY><TI_TOWN>Rostock</TI_TOWN><TI_TEXT><P>Antiinfektiva medel för systemiskt bruk, vacciner, cytostatika/cytotoxiska medel, samt immunmodulerande medel</P></TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="DE">Centogene AG</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="DE"><LEGAL_BASIS VALUE="32014L0024"/><CONTRACTING_BODY><ADDRESS_CONTRACTING_BODY><OFFICIALNAME>Centogene AG</OFFICIALNAME><ADDRESS>Am Strande 7</ADDRESS><TOWN>Rostock</TOWN><POSTAL_CODE>18055</POSTAL_CODE><COUNTRY VALUE="DE"/><CONTACT_POINT>Department Procurement</CONTACT_POINT><PHONE>+49 38180113540</PHONE><E_MAIL>christine.hirsch@centogene.com</E_MAIL><n2016:NUTS CODE="DE803"/><URL_GENERAL>https://www.centogene.com</URL_GENERAL></ADDRESS_CONTRACTING_BODY><CENTRAL_PURCHASING/><CA_TYPE_OTHER>Labordiagnostik</CA_TYPE_OTHER><CA_ACTIVITY VALUE="HEALTH"/></CONTRACTING_BODY><OBJECT_CONTRACT><TITLE><P>Beschaffung von Labormaterialien für die Genom-, Exom- und Gen-Panel-Sequenzierung</P></TITLE><CPV_MAIN><CPV_CODE CODE="33650000"/></CPV_MAIN><TYPE_CONTRACT CTYPE="SUPPLIES"/><SHORT_DESCR><P>Für die Durchführung von Prozessen für die Genom-, Exom-, Gen-Panel Sequenzierung mittels Gerätesytemen von Illumina werden Verbrauchsmaterialien benötigt.</P></SHORT_DESCR><VAL_TOTAL CURRENCY="USD">65000.00</VAL_TOTAL><NO_LOT_DIVISION/><OBJECT_DESCR ITEM="1"><n2016:NUTS CODE="DE803"/><MAIN_SITE><P>Rostock</P></MAIN_SITE><SHORT_DESCR><P>Lieferung von Verbrauchsmaterialien für Illumina Sequenzierautomaten.</P></SHORT_DESCR><AC><AC_PRICE/></AC><NO_OPTIONS/><EU_PROGR_RELATED><P>TBI-V-1-081-VBU-028</P></EU_PROGR_RELATED></OBJECT_DESCR></OBJECT_CONTRACT><PROCEDURE><PT_AWARD_CONTRACT_WITHOUT_CALL><D_ACCORDANCE_ARTICLE><D_MANUF_FOR_RESEARCH CTYPE="SUPPLIES"/></D_ACCORDANCE_ARTICLE><D_JUSTIFICATION><P>Der Auftraggeber betreibt seit 2015 bis zum heutigen Tag 10 Sequenzierautomaten der Firma Illumina. Die Prozesse für diese Gerätesysteme sind validiert und durch die amerikanische Akreditierungsinstitution CAP/CLIA bestätigt. Eine valdierte Freigabe zur Betreibung dieser Automaten setzt die Verwendung der Verbrauchsmaterialien der Firma Illumina sl Hersteller voraus. Eine Verwendung anderer Materialien ist nicht zulässig, somit ergibt sich eine entsprechende Ausschließlichkeit.</P></D_JUSTIFICATION></PT_AWARD_CONTRACT_WITHOUT_CALL><NO_CONTRACT_COVERED_GPA/></PROCEDURE><AWARD_CONTRACT ITEM="1"><CONTRACT_NO>EB-19-002233</CONTRACT_NO><TITLE><P>Lieferung von Kits</P></TITLE><AWARDED_CONTRACT><DATE_CONCLUSION_CONTRACT>2019-08-05</DATE_CONCLUSION_CONTRACT><TENDERS><NB_TENDERS_RECEIVED>1</NB_TENDERS_RECEIVED></TENDERS><CONTRACTORS><NO_AWARDED_TO_GROUP/><CONTRACTOR><ADDRESS_CONTRACTOR><OFFICIALNAME>Illumina GmbH</OFFICIALNAME><ADDRESS>Zeppelinstr. 71-73</ADDRESS><TOWN>München</TOWN><POSTAL_CODE>81669</POSTAL_CODE><COUNTRY VALUE="DE"/><PHONE>+49 8938035677</PHONE><E_MAIL>efunk@illumina.com</E_MAIL><n2016:NUTS CODE="DE212"/><URL>www.illumina.com</URL></ADDRESS_CONTRACTOR><NO_SME/></CONTRACTOR></CONTRACTORS><VALUES><VAL_ESTIMATED_TOTAL CURRENCY="USD">65000.00</VAL_ESTIMATED_TOTAL><VAL_TOTAL CURRENCY="USD">65000.00</VAL_TOTAL></VALUES></AWARDED_CONTRACT></AWARD_CONTRACT><COMPLEMENTARY_INFO><ADDRESS_REVIEW_BODY><OFFICIALNAME>Vergabekammer MV</OFFICIALNAME><ADDRESS>Johannes-Stelling-Str.14</ADDRESS><TOWN>Schwerin</TOWN><POSTAL_CODE>19053</POSTAL_CODE><COUNTRY VALUE="DE"/><PHONE>+49 3855885160</PHONE><E_MAIL>vergabekammer@wm.mv-regierung.de</E_MAIL><FAX>+49 3855884855817</FAX><URL>https://www.regierung-mv.de/</URL></ADDRESS_REVIEW_BODY><REVIEW_PROCEDURE><P>Verstöße gegen Vergabevorschriften sind spätestens bis zum Ablauf der Frist, 30 Kalendertage, nach der Veröffentlichung der Bekanntmachung der Auftragsvergabe im Amtsblatt der EU.</P></REVIEW_PROCEDURE><ADDRESS_REVIEW_INFO><OFFICIALNAME>analog VI.4.2</OFFICIALNAME><TOWN>Schwerin</TOWN><COUNTRY VALUE="DE"/></ADDRESS_REVIEW_INFO><DATE_DISPATCH_NOTICE>2019-09-06</DATE_DISPATCH_NOTICE></COMPLEMENTARY_INFO></F03_2014></FORM_SECTION></TED_EXPORT>